Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluation

PLoS Med. 2020 Jul 17;17(7):e1003194. doi: 10.1371/journal.pmed.1003194. eCollection 2020 Jul.

Abstract

Background: The current organized screening program for colorectal cancer in Germany offers both sexes 5 annual fecal immunochemical tests (FITs) between ages 50 and 54 years, followed by a first screening colonoscopy at age 55 years if all of these FITs were negative. We sought to assess the implications of this approach for key parameters of diagnostic performance.

Methods and findings: Using a multistate Markov model, we estimated the expected detection rates of advanced neoplasms (advanced adenomas and cancers) and number needed to scope (NNS) to detect 1 advanced neoplasm at a first screening colonoscopy conducted at age 55 after 5 preceding negative FITs and compared them with the corresponding estimates for a first screening colonoscopy at age 55 with no preceding FIT testing. In individuals with 5 consecutive negative FITs undergoing screening colonoscopy at age 55, expected colonoscopy detection rate (NNS) was 3.7% (27) and 0.10% (1,021) for any advanced neoplasm and cancer, respectively, in men, and 2.1% (47) and 0.05% (1,880) for any advanced neoplasm and cancer, respectively, in women. These NNS values for detecting 1 advanced neoplasm are approximately 3-fold higher, and the NNS values for detecting 1 cancer are approximately 8-fold higher, than those for a first screening colonoscopy at age 55 without prior FITs. This study is limited by model simplifying assumptions and uncertainties related to input parameters.

Conclusions: Screening colonoscopy at age 55 after 5 consecutive negative FITs at ages 50-54, as currently offered in the German cancer early detection program, is expected to have very low positive predictive value. Our results may inform efforts to enhance the design of screening programs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Colonoscopy / methods
  • Colorectal Neoplasms / diagnosis*
  • Colorectal Neoplasms / prevention & control*
  • Early Detection of Cancer / methods*
  • Feces
  • Female
  • Germany
  • Humans
  • Immunochemistry
  • Male
  • Markov Chains
  • Mass Screening / methods*
  • Middle Aged
  • Models, Theoretical*
  • Sensitivity and Specificity

Grants and funding

This work was supported by the German Federal Ministry of Education and Research (grant number 01GL1712, received by HB). The sponsor had no role in the study design; collection, analysis, and interpretation of data; writing of the report; and decision to submit the article for publication. TH was supported by the Helmholtz International Graduate School for Cancer Research at the German Cancer Research Centre (DKFZ).